UpToDate
Official reprint from UpToDate®
www.uptodate.com ©2016 UpToDate®

Capnocytophaga

Author
Marcia B Goldberg, MD
Section Editor
Stephen B Calderwood, MD
Deputy Editor
Elinor L Baron, MD, DTMH

INTRODUCTION

Capnocytophaga canimorsus is a bacterial cause of fulminant sepsis among individuals who have been bitten by a dog; patients at greatest risk include immunocompromised individuals, particularly those with asplenia, functional asplenia, cirrhosis, or history of heavy alcohol use. C. canimorsus and other Capnocytophaga species also cause a variety of other infections, including in immunocompetent hosts.

Issues related to Capnocytophaga infection will be reviewed here. Issues related to initial management of animal and human bites and to soft tissue infections due to dog and cat bites are discussed separately. (See "Initial management of animal and human bites" and "Soft tissue infections due to dog and cat bites".)

EPIDEMIOLOGY

Capnocytophaga species cause rare but severe infection in humans. The incidence of infection due to C. canimorsus in the general population is low. National surveillance for Capnocytophaga species is not performed in the United States; a national survey in the Netherlands noted 0.67 cases per million per year [1]. The prevalence among immunocompromised hosts is likely substantially higher than that of the general population. The case fatality rate in case series is 28 to 31 percent [2-4]; mortality is high even among patients who are immunocompetent.

C. canimorsus is the most common cause of severe Capnocytophaga infection in humans. Risk factors for C. canimorsus infection include a history of a dog bite and immunocompromise, particularly asplenia, functional asplenia, cirrhosis, or history of heavy alcohol use. Most (72 to 74 percent) of these infections occur in men, with a peak among individuals 50 to 70 years old [1,2,5]. Approximately half (43 to 56 percent) of patients report a history of a dog bite; others report scratches from dogs or occasionally cats or exposure to dogs without bites or scratches [1-4,6].

MICROBIOLOGY

Capnocytophaga is a genus in the family Flavobacteriaceae. Capnocytophaga species are slow growing, capnophilic ("carbon loving"), facultative anaerobes. They are long, thin, and generally fusiform gram-negative rods (picture 1), which may become pleomorphic with prolonged growth.

        

Subscribers log in here

To continue reading this article, you must log in with your personal, hospital, or group practice subscription. For more information or to purchase a personal subscription, click below on the option that best describes you:
Literature review current through: Nov 2016. | This topic last updated: Thu Sep 29 00:00:00 GMT 2016.
The content on the UpToDate website is not intended nor recommended as a substitute for medical advice, diagnosis, or treatment. Always seek the advice of your own physician or other qualified health care professional regarding any medical questions or conditions. The use of this website is governed by the UpToDate Terms of Use ©2016 UpToDate, Inc.
References
Top
  1. van Dam AP, Jansz A. Capnocytophaga canimorsus infections in The Netherlands: a nationwide survey. Clin Microbiol Infect 2011; 17:312.
  2. Pers C, Gahrn-Hansen B, Frederiksen W. Capnocytophaga canimorsus septicemia in Denmark, 1982-1995: review of 39 cases. Clin Infect Dis 1996; 23:71.
  3. Brenner DJ, Hollis DG, Fanning GR, Weaver RE. Capnocytophaga canimorsus sp. nov. (formerly CDC group DF-2), a cause of septicemia following dog bite, and C. cynodegmi sp. nov., a cause of localized wound infection following dog bite. J Clin Microbiol 1989; 27:231.
  4. Kullberg BJ, Westendorp RG, van 't Wout JW, Meinders AE. Purpura fulminans and symmetrical peripheral gangrene caused by Capnocytophaga canimorsus (formerly DF-2) septicemia--a complication of dog bite. Medicine (Baltimore) 1991; 70:287.
  5. Janda JM, Graves MH, Lindquist D, Probert WS. Diagnosing Capnocytophaga canimorsus infections. Emerg Infect Dis 2006; 12:340.
  6. Yamamoto U, Kunita M, Mohri M. Shock following a cat scratch. BMJ Case Rep 2013; 2013.
  7. Zangenah S, Abbasi N, Andersson AF, Bergman P. Whole genome sequencing identifies a novel species of the genus Capnocytophaga isolated from dog and cat bite wounds in humans. Sci Rep 2016; 6:22919.
  8. Curtis MA, Zenobia C, Darveau RP. The relationship of the oral microbiotia to periodontal health and disease. Cell Host Microbe 2011; 10:302.
  9. Dewhirst FE, Chen T, Izard J, et al. The human oral microbiome. J Bacteriol 2010; 192:5002.
  10. Takeshita T, Yasui M, Shibata Y, et al. Dental plaque development on a hydroxyapatite disk in young adults observed by using a barcoded pyrosequencing approach. Sci Rep 2015; 5:8136.
  11. Zaura E, Keijser BJ, Huse SM, Crielaard W. Defining the healthy "core microbiome" of oral microbial communities. BMC Microbiol 2009; 9:259.
  12. Umeda K, Hatakeyama R, Abe T, et al. Distribution of Capnocytophaga canimorsus in dogs and cats with genetic characterization of isolates. Vet Microbiol 2014; 171:153.
  13. Suzuki M, Kimura M, Imaoka K, Yamada A. Prevalence of Capnocytophaga canimorsus and Capnocytophaga cynodegmi in dogs and cats determined by using a newly established species-specific PCR. Vet Microbiol 2010; 144:172.
  14. van Dam AP, van Weert A, Harmanus C, et al. Molecular characterization of Capnocytophaga canimorsus and other canine Capnocytophaga spp. and assessment by PCR of their frequencies in dogs. J Clin Microbiol 2009; 47:3218.
  15. Mally M, Paroz C, Shin H, et al. Prevalence of Capnocytophaga canimorsus in dogs and occurrence of potential virulence factors. Microbes Infect 2009; 11:509.
  16. Mally M, Shin H, Paroz C, et al. Capnocytophaga canimorsus: a human pathogen feeding at the surface of epithelial cells and phagocytes. PLoS Pathog 2008; 4:e1000164.
  17. Manfredi P, Renzi F, Mally M, et al. The genome and surface proteome of Capnocytophaga canimorsus reveal a key role of glycan foraging systems in host glycoproteins deglycosylation. Mol Microbiol 2011; 81:1050.
  18. Renzi F, Manfredi P, Dol M, et al. Glycan-foraging systems reveal the adaptation of Capnocytophaga canimorsus to the dog mouth. MBio 2015; 6:e02507.
  19. Renzi F, Manfredi P, Mally M, et al. The N-glycan glycoprotein deglycosylation complex (Gpd) from Capnocytophaga canimorsus deglycosylates human IgG. PLoS Pathog 2011; 7:e1002118.
  20. Popiel KY, Vinh DC. 'Bobo-Newton syndrome': An unwanted gift from man's best friend. Can J Infect Dis Med Microbiol 2013; 24:209.
  21. Shin H, Mally M, Kuhn M, et al. Escape from immune surveillance by Capnocytophaga canimorsus. J Infect Dis 2007; 195:375.
  22. Shin H, Mally M, Meyer S, et al. Resistance of Capnocytophaga canimorsus to killing by human complement and polymorphonuclear leukocytes. Infect Immun 2009; 77:2262.
  23. Chiappa V, Chang CY, Sellas MI, et al. Case records of the Massachusetts General Hospital. Case 10-2014. A 45-year-old man with a rash. N Engl J Med 2014; 370:1238.
  24. Maury S, Leblanc T, Rousselot P, et al. Bacteremia due to Capnocytophaga species in patients with neutropenia: high frequency of beta-lactamase-producing strains. Clin Infect Dis 1999; 28:1172.
  25. Martino R, Rámila E, Capdevila JA, et al. Bacteremia caused by Capnocytophaga species in patients with neutropenia and cancer: results of a multicenter study. Clin Infect Dis 2001; 33:E20.
  26. Bonatti H, Rossboth DW, Nachbaur D, et al. A series of infections due to Capnocytophaga spp in immunosuppressed and immunocompetent patients. Clin Microbiol Infect 2003; 9:380.
  27. Kim JA, Hong SK, Kim EC. Capnocytophaga sputigena bacteremia in a patient with chronic lymphocytic leukemia. Ann Lab Med 2014; 34:325.
  28. Ugai T, Sugihara H, Nishida Y, et al. Capnocytophaga canimorsus sepsis following BMT in a patient with AML: possible association with functional asplenia. Bone Marrow Transplant 2014; 49:153.
  29. Christiansen CB, Berg RM, Plovsing RR, Møller K. Two cases of infectious purpura fulminans and septic shock caused by Capnocytophaga canimorsus transmitted from dogs. Scand J Infect Dis 2012; 44:635.
  30. Coutance G, Labombarda F, Pellissier A, et al. Capnocytophaga canimorsus endocarditis with root abscess in a patient with a bicuspid aortic valve. Heart Int 2009; 4:e5.
  31. Hayani O, Higginson LA, Toye B, Burwash IG. Man's best friend? Infective endocarditis due to Capnocytophaga canimorsus. Can J Cardiol 2009; 25:e130.
  32. Li A, Tambyah P, Chan D, Leong KK. Capnocytophaga sputigena empyema. J Clin Microbiol 2013; 51:2772.
  33. Nishioka H, Kozuki T, Kamei H. Capnocytophaga canimorsus bacteremia presenting with acute cholecystitis after a dog bite. J Infect Chemother 2015; 21:215.
  34. Cabellos C, Verdaguer R, Olmo M, et al. Community-acquired bacterial meningitis in elderly patients: experience over 30 years. Medicine (Baltimore) 2009; 88:115.
  35. Brichacek M, Blake P, Kao R. Capnocytophaga canimorsus infection presenting with complete splenic infarction and thrombotic thrombocytopenic purpura: a case report. BMC Res Notes 2012; 5:695.
  36. Chan JF, Wong SS, Leung SS, et al. Capnocytophaga sputigena primary iliopsoas abscess. J Med Microbiol 2010; 59:1368.
  37. Ma A, Goetz MB. Capnocytophaga canimorsus sepsis with associated thrombotic thrombocytopenic purpura. Am J Med Sci 2013; 345:78.
  38. Rougemont M, Ratib O, Wintsch J, et al. Capnocytophaga canimorsus prosthetic aortitis in an HIV-positive woman. J Clin Microbiol 2013; 51:2769.
  39. Sadjadi SA, Obedoza P, Devera R. Double zoonotic peritonitis. Am J Case Rep 2012; 13:279.
  40. Sandoe JA. Capnocytophaga canimorsus endocarditis. J Med Microbiol 2004; 53:245.
  41. Thirumala R, Rappo U, Babady NE, et al. Capnocytophaga lung abscess in a patient with metastatic neuroendocrine tumor. J Clin Microbiol 2012; 50:204.
  42. Ciantar M, Gilthorpe MS, Hurel SJ, et al. Capnocytophaga spp. in periodontitis patients manifesting diabetes mellitus. J Periodontol 2005; 76:194.
  43. Fredricks DN, Schubert MM, Myerson D. Molecular identification of an invasive gingival bacterial community. Clin Infect Dis 2005; 41:e1.
  44. Lopez E, Raymond J, Patkai J, et al. Capnocytophaga species and preterm birth: case series and review of the literature. Clin Microbiol Infect 2010; 16:1539.
  45. de Boer MG, Lambregts PC, van Dam AP, van 't Wout JW. Meningitis caused by Capnocytophaga canimorsus: when to expect the unexpected. Clin Neurol Neurosurg 2007; 109:393.
  46. Gasch O, Fernández N, Armisen A, et al. Community-acquired Capnocytophaga canimorsus meningitis in adults: report of one case with a subacute course and deafness, and literature review. Enferm Infecc Microbiol Clin 2009; 27:33.
  47. Monrad RN, Hansen DS. Three cases of Capnocytophaga canimorsus meningitis seen at a regional hospital in one year. Scand J Infect Dis 2012; 44:320.
  48. Mirza I, Wolk J, Toth L, et al. Waterhouse-Friderichsen syndrome secondary to Capnocytophaga canimorsus septicemia and demonstration of bacteremia by peripheral blood smear. Arch Pathol Lab Med 2000; 124:859.
  49. de Melo Oliveira MG, Abels S, Zbinden R, et al. Accurate identification of fastidious Gram-negative rods: integration of both conventional phenotypic methods and 16S rRNA gene analysis. BMC Microbiol 2013; 13:162.
  50. Ciantar M, Newman HN, Wilson M, Spratt DA. Molecular identification of Capnocytophaga spp. via 16S rRNA PCR-restriction fragment length polymorphism analysis. J Clin Microbiol 2005; 43:1894.
  51. Zangenah S, Ozenci V, Boräng S, Bergman P. Identification of blood and wound isolates of C. canimorsus and C. cynodegmi using VITEK2 and MALDI-TOF. Eur J Clin Microbiol Infect Dis 2012; 31:2631.
  52. Ehrmann E, Handal T, Tamanai-Shacoori Z, et al. High prevalence of β-lactam and macrolide resistance genes in human oral Capnocytophaga species. J Antimicrob Chemother 2014; 69:381.
  53. Guillon H, Eb F, Mammeri H. Characterization of CSP-1, a novel extended-spectrum beta-lactamase produced by a clinical isolate of Capnocytophaga sputigena. Antimicrob Agents Chemother 2010; 54:2231.
  54. Jolivet-Gougeon A, Tamanai-Shacoori Z, Desbordes L, et al. Genetic analysis of an ambler class A extended-spectrum beta-lactamase from Capnocytophaga ochracea. J Clin Microbiol 2004; 42:888.
  55. Rosenau A, Cattier B, Gousset N, et al. Capnocytophaga ochracea: characterization of a plasmid-encoded extended-spectrum TEM-17 beta-lactamase in the phylum Flavobacter-bacteroides. Antimicrob Agents Chemother 2000; 44:760.
  56. Arlet G, Sanson-Le Pors MJ, Casin IM, et al. In vitro susceptibility of 96 Capnocytophaga strains, including a beta-lactamase producer, to new beta-lactam antibiotics and six quinolones. Antimicrob Agents Chemother 1987; 31:1283.
  57. Hawkey PM, Smith SD, Haynes J, et al. In vitro susceptibility of Capnocytophaga species to antimicrobial agents. Antimicrob Agents Chemother 1987; 31:331.
  58. Roscoe DL, Zemcov SJ, Thornber D, et al. Antimicrobial susceptibilities and beta-lactamase characterization of Capnocytophaga species. Antimicrob Agents Chemother 1992; 36:2197.
  59. Geisler WM, Malhotra U, Stamm WE. Pneumonia and sepsis due to fluoroquinolone-resistant Capnocytophaga gingivalis after autologous stem cell transplantation. Bone Marrow Transplant 2001; 28:1171.